Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-20-002975
Filing Date
2020-01-31
Accepted
2020-01-31 19:22:32
Documents
2
Period of Report
2020-01-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 12170
2 POWER OF ATTORNEY (PUBLIC): POA doc1.txt EX-24 3018
  Complete submission text file 0001127602-20-002975.txt   16591
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Wilfong Diane E. (Reporting) CIK: 0001374988 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19731 | Film No.: 20566540